Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,577,393
-
Total 13F shares
-
21,121,086
-
Share change
-
-5,406,514
-
Total reported value
-
$140,722,888
-
Put/Call ratio
-
144%
-
Price per share
-
$6.66
-
Number of holders
-
82
-
Value change
-
-$35,953,961
-
Number of buys
-
44
-
Number of sells
-
40
Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF) as of Q3 2021
As of 30 Sep 2021,
Cardiff Oncology, Inc. - Common Stock (CRDF) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,121,086 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, CAXTON CORP, BlackRock Inc., VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, Octagon Capital Advisors LP, CITADEL ADVISORS LLC, Artal Group S.A., TWO SIGMA ADVISERS, LP, and STATE STREET CORP.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.